In re Blue Cross Blue Shield Antitrust Litigation: Represented Blue Cross Blue Shield Association in putative consolidated class action brought by all Blue insured and healthcare providers challenging the structure of the Blue Cross Blue Shield system under the antitrust laws.
Paragon Litigation Trust v. Noble Offshore plc et al.: Trial counsel for the Paragon Litigation Trust in a multi-billion dollar fraudulent transfer and breach of fiduciary duty action in U.S. Bankruptcy Court for the District of Delaware challenging Noble’s spin-off of Paragon.
In re Plasma Derivative Protein Therapies Litigation: Represented defendant in federal putative class actions alleging agreement among plasma producers to restrict output and exchange information to facilitate restricted output for certain plasma therapies.
Successfully represented various private equity firms and their portfolio companies in a wide range of disputes including deal-related indemnification and breach of contract litigation.
Represented major pharmaceutical company in Department of Justice investigation concerning FDA cGMP violations.
